Quarry LP bought a new stake in Abacus Life, Inc. (NASDAQ:ABL – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 47,944 shares of the company’s stock, valued at approximately $463,000.
Separately, Barclays PLC purchased a new position in shares of Abacus Life in the third quarter valued at $47,000.
Abacus Life Price Performance
Shares of NASDAQ ABL opened at $10.30 on Friday. The stock has a market cap of $658.38 million, a PE ratio of 515.26 and a beta of 0.17. Abacus Life, Inc. has a fifty-two week low of $5.47 and a fifty-two week high of $13.25. The company has a debt-to-equity ratio of 1.03, a quick ratio of 3.12 and a current ratio of 3.12. The stock has a fifty day moving average of $11.53 and a 200-day moving average of $11.05.
Analyst Upgrades and Downgrades
Separately, B. Riley initiated coverage on Abacus Life in a research report on Friday, May 31st. They issued a “buy” rating and a $16.00 price target for the company.
Check Out Our Latest Stock Analysis on ABL
Abacus Life Company Profile
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
See Also
- Five stocks we like better than Abacus Life
- Options Trading – Understanding Strike Price
- Top 5 High-Performance Cryptocurrency ETFs to Watch
- There Are Different Types of Stock To Invest In
- 3 Stocks That Plummeted After the Post-Fed Speech Crash
- What is a Stock Market Index and How Do You Use Them?
- Adobe Stock: It’s Not Too Late To Buy The Dip
Want to see what other hedge funds are holding ABL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Abacus Life, Inc. (NASDAQ:ABL – Free Report).
Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.